Tumors

Distribution by Scientific Domains
Distribution within Medical Sciences

Kinds of Tumors

  • Ew tumor
  • Glomu tumor
  • Wilm tumor
  • abdominal tumor
  • adenomatoid tumor
  • adnexal tumor
  • adrenal cortical tumor
  • adrenal tumor
  • advanced tumor
  • aggressive tumor
  • ameloblastic tumor
  • and neck tumor
  • angiectatic tumor
  • astrocytic tumor
  • base tumor
  • benign bone tumor
  • benign tumor
  • bilateral tumor
  • bladder tumor
  • bone tumor
  • borderline ovarian tumor
  • borderline tumor
  • brain tumor
  • breast tumor
  • brown tumor
  • carcinoid tumor
  • cell tumor
  • central nervous system tumor
  • childhood brain tumor
  • chondromyxoid tumor
  • cm tumor
  • cns tumor
  • colon tumor
  • colonic tumor
  • colorectal tumor
  • common malignant tumor
  • common mesenchymal tumor
  • common primary brain tumor
  • common tumor
  • composite tumor
  • control tumor
  • cord tumor
  • cortical tumor
  • cutaneous tumor
  • cystic tumor
  • dabska tumor
  • de novo tumor
  • desmoid tumor
  • desmoplastic small round cell tumor
  • detectable tumor
  • different tumor
  • eccrine tumor
  • ectomesenchymal chondromyxoid tumor
  • embryonal tumor
  • endocrine tumor
  • endodermal sinus tumor
  • entire tumor
  • epidermal tumor
  • epithelial ovarian tumor
  • epithelial salivary gland tumor
  • epithelial tumor
  • esophageal tumor
  • established tumor
  • expressing tumor
  • extragonadal germ cell tumor
  • fibrohistiocytic tumor
  • fibrous tumor
  • gastric tumor
  • gastrointestinal mesenchymal tumor
  • gastrointestinal stromal tumor
  • gastrointestinal tumor
  • germ cell tumor
  • giant cell tumor
  • gland tumor
  • glial tumor
  • glomu jugulare tumor
  • glomu tumor
  • glottic tumor
  • grade 3 tumor
  • grade i tumor
  • grade ii tumor
  • grade iii tumor
  • grade tumor
  • granular cell tumor
  • granulosa cell tumor
  • hcc tumor
  • head and neck tumor
  • hepatic tumor
  • hepatocellular tumor
  • high-grade tumor
  • hpv-negative tumor
  • hpv-positive tumor
  • human brain tumor
  • human prostate tumor
  • human solid tumor
  • human tumor
  • hypoxic tumor
  • i tumor
  • ii tumor
  • iii tumor
  • individual tumor
  • inflammatory myofibroblastic tumor
  • intracranial tumor
  • intraductal papillary mucinous tumor
  • invasive tumor
  • iv tumor
  • jugulare tumor
  • large cell calcifying sertoli cell tumor
  • large tumor
  • larger tumor
  • laryngeal tumor
  • leave renal tumor
  • lipomatou tumor
  • liver tumor
  • localized tumor
  • low-grade tumor
  • lung tumor
  • macroscopic tumor
  • malignant bone tumor
  • malignant brain tumor
  • malignant glomu tumor
  • malignant liver tumor
  • malignant ovarian tumor
  • malignant peripheral nerve sheath tumor
  • malignant rhabdoid tumor
  • malignant salivary gland tumor
  • malignant skin tumor
  • malignant triton tumor
  • malignant tumor
  • malignant vascular tumor
  • mammary tumor
  • many human tumor
  • many tumor
  • mast cell tumor
  • melanocytic tumor
  • melanoma tumor
  • mesenchymal tumor
  • metastatic brain tumor
  • metastatic gastrointestinal stromal tumor
  • metastatic liver tumor
  • metastatic prostate tumor
  • metastatic tumor
  • mixed germ cell tumor
  • mixed tumor
  • mouse tumor
  • mucinous ovarian tumor
  • mucinous tumor
  • multifocal tumor
  • multiple tumor
  • muscle tumor
  • myofibroblastic tumor
  • nasopharyngeal tumor
  • neck tumor
  • negative tumor
  • nerve sheath tumor
  • nervous system tumor
  • neural tumor
  • neuroblastic tumor
  • neuroectodermal tumor
  • neuroendocrine tumor
  • neuroepithelial tumor
  • odontogenic tumor
  • of solid tumor
  • of tumor
  • oligodendroglial tumor
  • one tumor
  • other solid tumor
  • other tumor
  • ovarian tumor
  • pancreatic endocrine tumor
  • pancreatic tumor
  • papillary mucinous tumor
  • papillary tumor
  • parenchymal tumor
  • pediatric brain tumor
  • pediatric solid tumor
  • pelvic tumor
  • peripheral nerve sheath tumor
  • peritoneal tumor
  • phyllode tumor
  • pineal parenchymal tumor
  • pituitary tumor
  • positive tumor
  • primary brain tumor
  • primary breast tumor
  • primary intracranial tumor
  • primary lung tumor
  • primary malignant tumor
  • primary ovarian tumor
  • primary tumor
  • primitive neuroectodermal tumor
  • prostate tumor
  • rare benign tumor
  • rare tumor
  • rat mammary tumor
  • rectal tumor
  • recurrent tumor
  • renal tumor
  • resected tumor
  • residual tumor
  • retroperitoneal tumor
  • rhabdoid tumor
  • right adrenal tumor
  • round cell tumor
  • sac tumor
  • salivary gland tumor
  • same tumor
  • second primary tumor
  • secondary tumor
  • sertoli cell tumor
  • several human tumor
  • several tumor
  • sheath tumor
  • single tumor
  • sinus tumor
  • skin tumor
  • skull base tumor
  • small round cell tumor
  • small tumor
  • smaller tumor
  • smooth muscle tumor
  • soft tissue tumor
  • soft-tissue tumor
  • solid tumor
  • solitary fibrous tumor
  • solitary tumor
  • spindle cell tumor
  • sporadic tumor
  • stage iv tumor
  • stage tumor
  • stromal tumor
  • subcutaneous tumor
  • submucosal tumor
  • system tumor
  • testicular germ cell tumor
  • testicular tumor
  • thyroid tumor
  • tissue tumor
  • tract tumor
  • treated tumor
  • triton tumor
  • uncommon tumor
  • unusual tumor
  • upper urinary tract tumor
  • urinary tract tumor
  • variety of solid tumor
  • variety of tumor
  • various malignant tumor
  • various tumor
  • vascular tumor
  • warthin tumor
  • xenograft tumor
  • xenografted tumor
  • yolk sac tumor

  • Terms modified by Tumors

  • tumor ablation
  • tumor aggressiveness
  • tumor angiogenesi
  • tumor antigen
  • tumor area
  • tumor bearing mouse
  • tumor behavior
  • tumor biology
  • tumor biomarker
  • tumor biopsy
  • tumor blood flow
  • tumor border
  • tumor burden
  • tumor case
  • tumor cell
  • tumor cell apoptosi
  • tumor cell detection
  • tumor cell differentiation
  • tumor cell growth
  • tumor cell invasion
  • tumor cell line
  • tumor cell lysis
  • tumor cell metastasis
  • tumor cell migration
  • tumor cell nest
  • tumor cell population
  • tumor cell proliferation
  • tumor cell survival
  • tumor cells.
  • tumor challenge
  • tumor characteristic
  • tumor classification
  • tumor clearance
  • tumor colonization
  • tumor component
  • tumor control
  • tumor data
  • tumor depth
  • tumor detection
  • tumor development
  • tumor diagnosis
  • tumor diameter
  • tumor differentiation
  • tumor dissemination
  • tumor emboli
  • tumor entity
  • tumor eradication
  • tumor excision
  • tumor exhibiting
  • tumor expression
  • tumor extension
  • tumor extent
  • tumor extirpation
  • tumor factor
  • tumor focus
  • tumor formation
  • tumor frequency
  • tumor gene
  • tumor grade
  • tumor growth
  • tumor growth delay
  • tumor growth inhibition
  • tumor growth kinetics
  • tumor growth rate
  • tumor growth suppression
  • tumor heterogeneity
  • tumor histology
  • tumor hypoxia
  • tumor imaging
  • tumor immunity
  • tumor immunology
  • tumor immunotherapy
  • tumor incidence
  • tumor induction
  • tumor infiltration
  • tumor inhibition
  • tumor initiation
  • tumor invasion
  • tumor invasiveness
  • tumor involvement
  • tumor larger
  • tumor lesion
  • tumor line
  • tumor load
  • tumor localization
  • tumor location
  • tumor lysate
  • tumor lysis syndrome
  • tumor malignancy
  • tumor management
  • tumor margin
  • tumor marker
  • tumor mass
  • tumor measurement
  • tumor measuring
  • tumor metabolism
  • tumor metastase
  • tumor metastasis
  • tumor microcirculation
  • tumor microenvironment
  • tumor model
  • tumor models
  • tumor necrosis
  • tumor necrosis factor
  • tumor necrosis factor alpha
  • tumor necrosis factor inhibitor
  • tumor necrosis factor receptor
  • tumor necrosis factor receptor i
  • tumor necrosis factor superfamily
  • tumor necrosis factor-alpha
  • tumor nest
  • tumor nodule
  • tumor number
  • tumor oxygenation
  • tumor pathology
  • tumor patient
  • tumor perfusion
  • tumor periphery
  • tumor phenotype
  • tumor progression
  • tumor proliferation
  • tumor promoter
  • tumor promotion
  • tumor recurrence
  • tumor recurrence rate
  • tumor registry
  • tumor regression
  • tumor regrowth
  • tumor rejection
  • tumor relapse
  • tumor removal
  • tumor resection
  • tumor resistance
  • tumor response
  • tumor response rate
  • tumor rupture
  • tumor sample
  • tumor section
  • tumor shape
  • tumor shrinkage
  • tumor site
  • tumor size
  • tumor specimen
  • tumor spectrum
  • tumor spread
  • tumor stage
  • tumor staging
  • tumor status
  • tumor stem cell
  • tumor stroma
  • tumor subtype
  • tumor suppression
  • tumor suppressor
  • tumor suppressor activity
  • tumor suppressor function
  • tumor suppressor gene
  • tumor suppressor pathway
  • tumor suppressor protein
  • tumor surface
  • tumor surgery
  • tumor susceptibility
  • tumor syndrome
  • tumor therapy
  • tumor thickness
  • tumor thrombus
  • tumor tissue
  • tumor tissue sample
  • tumor treatment
  • tumor type
  • tumor uptake
  • tumor vaccine
  • tumor vascularity
  • tumor vascularization
  • tumor vasculature
  • tumor vessel
  • tumor volume
  • tumor weight
  • tumor xenograft

  • Selected Abstracts


    WHAT KIND OF BENEFIT DO WE EXPECT FOR PERORAL PANCREATOSCOPY IN THE DIAGNOSIS OF INTRADUCTAL PAPILLARY MUCINOUS TUMOR OF THE PANCREAS?

    DIGESTIVE ENDOSCOPY, Issue 2006
    Taketo Yamaguchi
    Intraductal papillary mucinous tumor (IPMT) of the pancreas is characterized by slow growth and a relatively favorable prognosis, however, invasive cancer originating in an IPMT is associated with a poor prognosis. Although various parameters in imaging modalities have been advocated to differentiate between benign IPMN and malignant ones, it is not easy to obtain definite diagnosis based on these parameters. Peroral pancreatoscopy (POPS) allows a clear and direct visualization of the pancreatic duct, providing useful information regarding tumor nature in IPMT. The authors have studied the usefulness of POPS in the diagnosis of IPMT. Nevertheless, its usefulness is not necessarily widely accepted and the significance of POPS is still controversial. In this review, the authors intended to address the diagnostic value of POPS and to clarify its role in the diagnosis of IPMT. The authors think treatment of IPMT can be improved by introducing POPS because the determination of surgical procedure as well as the area of resection based on the preoperative diagnosis of the involvement of the main pancreatic duct and branch duct is inevitable. [source]


    COMPARISON OF THE HEIGHT OF PAPILLARY TUMOR IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS BETWEEN MEASURED PREOPERATIVE IMAGES AND RESECTED MATERIAL

    DIGESTIVE ENDOSCOPY, Issue 2006
    Kiyohito Tanaka
    The height of the mural nodules and papillary tumors in main pancreatic duct or dilated branch duct is the most important factor for diagnosis of intraductal papillary mucinous neoplasm (IPMN). In this study, the authors compared the height of the papillary lesions and mural nodules between the height of resected tissues and the height detected by the preoperative imaging tools (endoscopic ultrasonography [EUS] and intraductal ultrasonography [IDUS]) in 38 patients with IPMN. In 21 out of 23 cases of adenoma, and in cases with the non-invasive cancer, the difference of the height of operative and preoperative analysis measured by EUS and IDUS was within 1,2 mm. EUS and IDUS are useful for diagnosis of degree of malignancy in IPMN. [source]


    35 YEAR-OLD MAN WITH FALCINE TUMOR

    BRAIN PATHOLOGY, Issue 5 2010
    Eytan Raz
    No abstract is available for this article. [source]


    POSTERIOR FOSSA TUMOR IN A 2 YEAR-OLD GIRL

    BRAIN PATHOLOGY, Issue 2 2009
    Turki Omar Al-Hussain MBBS
    First page of article [source]


    A 10-MONTH-OLD BOY WITH A LARGE PINEAL TUMOR

    BRAIN PATHOLOGY, Issue 3 2005
    Inga Gudinaviciene
    February 2005. Case report of a 10-month-old boy with a large tumor located in the pineal gland, consisting of glia, ganglion cells, pigmented neuroepithelium and striated muscle, without immature components. The combination of neuroectodermal and mesenchymal constituents includes entities as pineal anlage tumor (melanotic neuroectodermal tumor of infancy, MNTI), ectomesenchymoma, medullomyoblastoma, and teratoma in the differential diagnosis. Lack of immature elements in this case, however, eliminates ectomesenchymoma and medullomyoblastoma from the differential diagnosis. Retinal anlage tumors, to be considered as MNTI at the site of the pineal gland, usually harbor immature components as well. Therefore, the present case does not match strict criteria of any of the categories mentioned and therefore we have designated it as a "pineal anlage tumor (without immature components)". [source]


    USEFUL ENDOSCOPIC ULTRASONOGRAPHY TO ASSESS THE EFFICACY OF NEOADJUVANT THERAPY FOR ADVANCED ESOPHAGEAL CARCINOMA: BASED ON THE RESPONSE EVALUATION CRITERIA IN SOLID TUMORS

    DIGESTIVE ENDOSCOPY, Issue 1 2005
    Masaho Ota
    Objective:, The aim of the present study was to assess the usefulness of endoscopic ultrasonography (EUS) for evaluating the efficacy of neoadjuvant therapy for advanced esophageal carcinoma based on the Response Evaluation Criteria in Solid Tumors (RECIST). Patients and Methods:, Sixty-two patients with advanced esophageal carcinoma underwent surgical resection after neoadjuvant therapy. The maximal tumor thickness was measured by EUS before and after neoadjuvant therapy, and the percent reduction was compared with the pathological response. Based on the RECIST, PD-SD (progressive disease-stable disease) was defined as < 30% reduction of tumor thickness on EUS, PR (partial response) as , 30% reduction of tumor thickness, and CR (complete response) as no detectable tumor (100%). Results:, The percent reduction of the thickness of Grade 0,1, Grade 2 and Grade 3 tumor was 11.5 ± 21.0%, 48.2 ± 17.0% and 74.9 ± 21.1%, respectively. There were significant differences in the extent of reduction among the three groups. Based on the RECIST, 80% of Grade 0,1 cases, 91% of Grade 2 cases and 22% of Grade 3 cases were PD-SD, PR, and CR according to EUS, respectively. EUS correctly identified 80% of non-responders and 94% of responders. Conclusions:, The percentage reduction of tumor thickness on EUS closely reflected the pathological evaluation. EUS evaluation based on the RECIST seems to be useful for monitoring neoadjuvant therapy in patients with esophageal carcinoma. [source]


    NEW ENDOSCOPIC TECHNIQUE TO CLOSE LARGE MUCOSAL DEFECTS AFTER ENDOSCOPIC MUCOSAL RESECTION IN PATIENTS WITH GASTRIC MUCOSAL TUMORS

    DIGESTIVE ENDOSCOPY, Issue 4 2004
    Masaki Endo
    Endoscopic mucosal resection has been recognized as a standard method for treating mucosal tumors of the stomach in Japan. In our department, we have treated mucosal defects after this procedure by using metallic clips to prevent and manage complications related to endoscopic mucosal resection. In the present study, we explain the new technique, the ,loop-and-clips' method, which uses clips and a detachable snare to close large mucosal defects after endoscopic mucosal resection. [source]


    ENDOSCOPIC MUCOSAL RESECTION AND SUBMUCOSAL DISSECTION METHOD FOR LARGE COLORECTAL TUMORS

    DIGESTIVE ENDOSCOPY, Issue 2004
    Yasushi Sano
    ABSTRACT The goal of endoscopic mucosal resection (EMR) is to allow the endoscopist to obtain tissue or resect lesions not previously amenable to standard biopsy or excisional techniques and to remove malignant lesions without open surgery. In this article, we describe the results of conventional EMR and EMR using an insulation-tipped (IT) electrosurgical knife (submucosal dissection method) for large colorectal mucosal neoplasms and discuss the problems and future prospects of these procedures. At present, conventional EMR is much more feasible than EMR using IT-knife from the perspectives of time, money, complication, and organ preservation. However, larger lesions tend to be resected in a piecemeal fashion; and it is difficult to confirm whether EMR has been complete. For accurate histopathological assessment of the resected specimen en bloc EMR is desirable although further experience is needed to establish its safety and efficacy. Further improvements of in EMR with special knife techniques are required to simply and safely remove large colorectal neoplasms. [source]


    Long-Pulse 595-nm Pulsed Dye Laser for the Treatment of a Glomus Tumor

    DERMATOLOGIC SURGERY, Issue 9 2010
    IRENE J. VERGILIS-KALNER MD
    The authors have indicated no significant interest with commercial supporters. [source]


    Letter: The Use of a Microscopic Grid to Localize Tumor on Sequential Mohs Micrographic Surgery Sections

    DERMATOLOGIC SURGERY, Issue 9 2007
    MICHELLE A. PIPITONE MD
    No abstract is available for this article. [source]


    Surgical Management of Giant Condyloma Acuminatum (Buschke-Loewenstein Tumor) of the Perianal Region

    DERMATOLOGIC SURGERY, Issue 5 2007
    FASA, KOSMAS I. PARASKEVAS MD
    First page of article [source]


    A Common Tumor, An Uncommon Location: Basal Cell Carcinoma of the Nipple and Areola in a 49-Year-Old Woman

    DERMATOLOGIC SURGERY, Issue 4 2005
    Nathan Rosen MD
    Background. Basal cell carcinoma (BCC) occurring on sun-protected regions is an uncommon phenomenon. BCC of the nipple is an exceedingly rare event. Method. We review the literature on BCC of the female nipple and herein describe the eighth reported case in the English literature. Our patient was treated with Mohs micrographic surgery and sentinel lymph node biopsy. Conclusion. BCC of the nipple are extremely rare tumors with unclear etiology. They can be aggressive and are capable of causing significant morbidity and mortality if they are neglected or improperly treated. With continued reporting of the diagnosis, treatment, and follow-up of these patients, we may gain an understanding of the pathogenesis, as well as the best method of control for these unusual tumors. [source]


    Malignant Glomus Tumor: A Case Report and Review of the Literature

    DERMATOLOGIC SURGERY, Issue 9 2001
    John D. Kayal MD
    Glomangiosarcoma, or malignant glomus tumor, is a very rare neoplasm that when seen typically arises from a benign glomus tumor. Despite having histologic features of malignancy, these tumors usually do not metastasize. However, when metastasis occurs this disease is often fatal. We report a case of a malignant glomus tumor arising de novo on the nose of an 89-year-old white woman, and we review the literature concerning glomangiosarcomas. [source]


    A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions

    DIAGNOSTIC CYTOPATHOLOGY, Issue 11 2007
    Shailja Garg M.B.B.S.
    Abstract The present study was undertaken to compare the efficacy of needle core biopsy (NCB) of the breast with fine-needle aspiration cytology (FNAC) in breast lesions (palpable and non-palpable) in the Indian set-up, along with the assessment of tumor grading with both the techniques. Fifty patients with suspicious breast lesions were subjected to simultaneous FNAC and ultrasound-guided NCB following an initial mammographic evaluation. Cases were categorized into benign, benign with atypia, suspicious and malignant groups. In cases of infiltrating duct carcinomas, grading was performed on cytological smears as well as on NCB specimens. Both the techniques were compared, and findings were correlated with radiological and excision findings. Out of 50 cases, 18 were found to be benign and 32 malignant on final pathological diagnosis. Maximum number of patients with benign diagnosis was in the fourth decade (42.11%) and malignant diagnosis in the fourth as well as fifth decade (35.48% each). Sensitivity and specificity of mammography for the diagnosis of malignancy was 84.37% and 83.33%, respectively. Sensitivity and specificity of FNAC for malignant diagnosis was 78.15% and 94.44%, respectively, and of NCB was 96.5% and 100%, respectively. But NCB had a slightly higher specimen inadequacy rate (8%). NCB improved diagnostic categorization over FNAC by 18%. Tumor grading in cases of IDC showed high concordance rate between NCB and subsequent excision biopsy (94.44%) but low concordance rate between NCB and FNAC (59.1%). NCB is superior to FNAC in the diagnosis of breast lesions in terms of sensitivity, specificity, correct histological categorization of the lesions as well as tumor grading. Diagn. Cytopathol. 2007;35:681,689. © 2007 Wiley-Liss, Inc. [source]


    Aortic Tumor or Mobile Thrombus?

    ECHOCARDIOGRAPHY, Issue 2 2010
    Andrea Loiselle M.D., M.P.H.
    Isolated large mobile mass in the thoracic aorta can be due to thrombus or, rarely, aortic tumor. We report the case of a 61-year-old man with no history of medical problems presenting with neurologic deficits and in whom a large mobile echogenic mass in the distal aortic arch was found with transesophageal echocardiography. Given his few cardiovascular risk factors and absence of other systemic symptoms, he received anticoagulant therapy. Subsequent resolution of the aortic mass suggested a diagnosis of thrombus. This case illustrates an unusual manifestation of aortic arch atherosclerosis and underscores the utility of transesophogeal echocardiography for patients with ischemic stroke. (Echocardiography 2010;27:E21-E22) [source]


    Hyaluronan and its receptors in mucoepidermoid carcinoma

    HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Issue 2 2006
    Richard O. Wein MD
    Abstract Background. Hyaluronan (HA) is a prominent extracellular matrix component undergoing continuous production and degradation. Increased HA levels have been described in a variety of tumors. The objective of this study was to examine the staining patterns of HA and two of its associated receptors (CD44 and HARE) in relation to the metastatic potential of mucoepidermoid carcinoma (MC). Immunohistochemical staining of preserved surgical specimens was used. Methods. Tissues from 12 patients with a histologic diagnosis of salivary MC (10 parotid, one submandibular gland, one minor salivary gland) were studied. Half (six of 12) of the patients had regional metastases. Tumor, normal salivary tissue, and regional lymph nodes were stained for HA, CD44, and HARE expression. Specimens were graded for staining intensity and a percent of the specimen stained. Results. Normal salivary tissue did not demonstrate epithelial cell surface HA expression, whereas HA was expressed on tumor cells and in regional lymph nodes containing metastases. These differences were both significant using Student's t test (p < .00002, and p < .0022, respectively). Tumors with positive nodes tended to have greater cell surface HA. Decreased expression or downregulation of HARE was also noted in involved lymph nodes. No differences in CD44 expression were seen between primary specimens and lymph nodes. The observed staining patterns for CD44 and HARE were not reflective of the metastatic potential of the primary MC. Conclusions. Increased HA expression was seen on mucoepidermoid carcinoma cells compared with adjacent normal salivary gland epithelium. This observation may assist in explaining the development of regional metastasis in these tumors. We did not identify specific HA, CD44, or HARE staining patterns in primary lesions that were predictive of regional metastases. © 2005 Wiley Periodicals, Inc. Head Neck27: XXX,XXX, 2005 [source]


    The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil

    HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Issue 1 2004
    Wei Li MMed
    Abstract Background. Chemical carcinogens induce squamous cell carcinoma (SCC) of the head and neck by targeting the p53 and the retinoblastoma (pRb) pathways. Human papillomavirus (HPV) might have an etiologic role in these cancers at particular sites. Few studies have compared cell cycle protein expression in HPV-positive and HPV-negative tumors in this region. Methods. Fifty tonsil SCCs were analyzed for HPV by PCR and for expression of cell cycle proteins (p53, pRb, p16INK4A, p21CIP1/WAF1, p27KIP1, and cyclinD1) by immunohistochemistry. Results. HPV was present in 42%; almost all were type 16. There were statistical associations between HPV positivity and reduced expression of pRb and cyclinD1, overexpression of p16, and younger patient age. Tumor with down-regulated p27 tended to have down-regulated pRb and p21. Conclusions. HPV-positive tonsil SCCs have distinct molecular pathways. Their association with younger patient age suggests that they are biologically distinct from HPV-negative tumors. © 2004 Wiley Periodicals, Inc. Head and Neck 26: 1,9, 2004 [source]


    Association between smoking during radiotherapy and prognosis in head and neck cancer: A follow-up study ,

    HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Issue 12 2002
    George P. Browman MD
    Abstract Background. The study objective was to confirm a previous finding that patients with stage III/IV squamous head and neck cancer (SHNC) who smoke during radiotherapy (RT) experience reduced survival. Methods. An observational cohort study. Patients' smoking status was assessed weekly by questionnaire plus blood cotinine. Patients were assessed every 3 to 4 months for survival. Logistic regression and Cox proportional hazards analyses were used to detect the independent contribution of smoking on survival. Results. Of 148 patients, 113 smoked during RT. Blood cotinine and smoking questionnaire responses were highly correlated (Spearman R = .69; p < .0005). Abstainers and very light smokers experienced better survival than light, moderate, and heavy smokers (median, 42 vs 29 months; p = .07). Tumor and nodal status and years smoked were the most important prognostic factors. Smoking during RT was not an independent predictor of survival, but baseline smoking status was (p = .016). Conclusion. Smoking status should be documented in all future trials of RT in SHNC to allow for pooled analyses with sufficient power to address this question. © 2002 Wiley Periodicals, Inc. Head Neck 24: 1031,1037, 2002 [source]


    Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions

    INTERNATIONAL JOURNAL OF CANCER, Issue 10 2008
    Jinhui Liao
    Abstract Expression of parathyroid hormone-related protein (PTHrP) correlates with prostate cancer skeletal progression; however, the impact of prostate cancer-derived PTHrP on the microenvironment and osteoblastic lesions in skeletal metastasis has not been completely elucidated. In this study, PTHrP overexpressing prostate cancer clones were stably established by transfection of full length rat PTHrP cDNA. Expression and secretion of PTHrP were verified by western blotting and IRMA assay. PTHrP overexpressing prostate cancer cells had higher growth rates in vitro, and generated larger tumors when inoculated subcutaneously into athymic mice. The impact of tumor-derived PTHrP on bone was investigated using a vossicle co-implant model. Histology revealed increased bone mass adjacent to PTHrP overexpressing tumor foci, with increased osteoblastogenesis, osteoclastogenesis and angiogenesis. In vitro analysis demonstrated pro-osteoclastic and pro-osteoblastic effects of PTHrP. PTHrP enhanced proliferation of bone marrow stromal cells and early osteoblast differentiation. PTHrP exerted a pro-angiogenic effect indirectly, as it increased angiogenesis but only in the presence of bone marrow stromal cells. These data suggest PTHrP plays a role in tumorigenesis in prostate cancer, and that PTHrP is a key mediator for communication and interactions between prostate cancer and the bone microenvironment. Prostate cancer-derived PTHrP is actively involved in osteoblastic skeletal progression. © 2008 Wiley-Liss, Inc. [source]


    DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients

    INTERNATIONAL JOURNAL OF CANCER, Issue 4 2006
    Coral V.A. Wynter
    Abstract Colorectal adenomas have traditionally been regarded as homogeneous. The aim of our study was to identify molecular features that may differentiate sporadic adenomas from familial adenomas such as Familial Adenomatous Polyposis (FAP) and Multiple Adenoma patients. DNA methylation was tested at Methylated IN Tumor (MINT) loci (1,2,12,31) and the CpG promoter region of genes MLH1, HPP1, MGMT, p14ARF and p16INK4a in FAP-associated adenomas (33) from 5 patients with a known APC mutation (Group 1, FAP), adenomas (29) from 4 Multiple Adenoma patients (Group 2 Multiple), adenomas (14) from 3 patients with sporadic colorectal cancers showing high microsatellite instability (Group 3, MSI-H) and adenomas (16) from 7 patients, with sporadic colorectal cancers showing microsatellite stable or low level instability (Group 4, MSS/MSI-L). Aberrant Crypt Foci (ACFs), Hyperplastic Polyps (HPs) and cancers were also examined for methylation status as well as K- ras mutation. Multiple Adenoma patients were examined for germline polymorphisms in the base excision repair gene, MYH. The familial syndrome, FAP -associated adenomas showed a significantly low frequency of MINT methylation (15.5%,) compared to sporadic MSS/MSI-L-associated adenomas (35.5%). Group 3 (MSI-H) adenomas were different in that many showed serration and a high level of methylation (57.1%). Group 2, Multiple Adenoma cases, resembled sporadic MSS/MSI-L-associated adenomas. However the promoter regions of key genes, MGMT, p14ARF and p16INK4a were methylated to a greater extent than MINTs in both sporadic and familial adenomas. Genetic profiling of adenomas supports the concept that adenomas belonging to familial syndromes pursue a different pathway to tumorigenesis than their sporadic counterpar/ts from their earliest formation. © 2005 Wiley-Liss, Inc. [source]


    Ectopic Parathyroid Tumor in the Sternohyoid Muscles: Supernumerary Gland in a Patient With MEN Type 1,

    JOURNAL OF BONE AND MINERAL RESEARCH, Issue 8 2005
    Daishu Miura MD
    No abstract is available for this article. [source]


    Oral myofibromatosis: an unusual cause of gingival overgrowth

    JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 11 2002
    Case report, review of the literature
    Abstract Background:, This case report describes a rare benign tumour, which presented as discrete areas of gingival hyperplasia affecting both the mandible and the maxilla. Method:, Surgical excision of the lesions was carried out under local anaesthetic. Histopathological examination confirmed the diagnosis of oral myofibromatosis. Results: The condition responded to surgical excision and appears to have limited growth potential. It affects a wide spectrum of ages and can be alarming due to rapid enlargement and ulceration, so careful diagnosis is important to avoid unnecessary aggressive treatment. Zusammenfassung Orale Myofibromatose: eine ungewöhnliche Ursache einer gingivalen HyperplasieFallbericht und Literaturüberblick Hintergründe: In dem vorliegenden Fallbericht wird ein seltener benigner Tumor, der sich als klar abgegrenzte Bereiche einer gingivalen Hyperplasie darstellte und durch den sowohl Mandibula als auch Maxilla betroffen waren, beschrieben. Methodik: Unter lokaler Betäubung wurde eine operative Exzision der Läsionen vorgenommen. Eine histopathologische Untersuchung bestätigte die Diagnose einer oralen Myofibromatose. Ergebnisse: Die Erkrankung sprach auf die operative Exzision an und scheint lediglich über begrenztes Wachstumspotential zu verfügen. Eine breites Spektrum an Altergruppen ist betroffen und die Störung kann aufgrund einer rapiden Vergrösserung und Ulzerierung alarmierend sein. Um unnötige aggressive Therapien zu vermeiden ist eine sorgfältige Diagnose erforderlich. Résumé Myofibromatose buccale : une cause inhabituelle d'hypertrophie gingivale. Rapport d'un cas et revue de la littérature Les myofibromatoses sont des néoplasmes bénins rares qui peuvent se présenter soit de maničre solitaire soit en lésions multiples. Un diagnostic attentif de cette tumeur bénigne est important pour éviter une thérapie aggressive non-nécessaire. Avec un traitement chirurgical conservateur, le pronostic est excellent. [source]


    Myxofibrosarcoma Initially Presenting as a Pleomorphic Hyalinizing Angiectatic Tumor (PHAT): is PHAT a Precursor or Unique Type of Myxofibrosarcoma?

    JOURNAL OF CUTANEOUS PATHOLOGY, Issue 1 2005
    David S Cassarino
    Myxofibrosarcoma (MFS) is a common soft tissue sarcoma of adults. We present an unusual case which initially showed features of a pleomorphic hyalinizing angiectatic tumor (PHAT). The lesion was characterized by abundant plump, eosinophilic cells exhibiting striking nuclear atypia, set in a dense, hyalinized stroma with a prominent, angiectatic vasculature. Rare mitotic figures were identified. These findings were felt to be most consistent with the diagnosis of PHAT. Four months after removal, local recurrence was noted, which demonstrated findings of a high grade MFS, including a cellular proliferation of pleomorphic spindle cells set in a prominent myxoid stroma. Multiple mitoses, including atypical ones, were present. In light of these findings, the original specimen was reexamined and the diagnosis was revised to high- grade MFS. MFS, especially low-grade lesions, may be confused with several benign lesions. Previous cases mimicking PHAT have not been reported. We describe a unique case of high-grade MFS which initially showed characteristic features of a PHAT, raising the possibility that MFS may occasionally arise in, or have areas that masquerade as, PHAT. It is possible that PHAT, currently considered a benign neoplasm, may actually represent a peculiar form of MFS of low malignant potential. [source]


    Cutaneous Congenital Plexiform Cellular Schwannoma: A Simulant of Malignant Peripheral Nerve Sheath Tumor of Childhood , A Case Report and Literature Review

    JOURNAL OF CUTANEOUS PATHOLOGY, Issue 1 2005
    M. Matthews
    Cutaneous plexiform schwannoma is a rare multilobulated variant of benign schwannoma. When presenting as the cellular subtype with significantly increased proliferative rate, diagnostic consideration of a malignant peripheral nerve sheath tumor is prompted. However, follow up demonstrates a benign natural history with propensity for local recurrence and typical lack of association with neurocutaneous syndromes. These lesions most commonly occur as cutaneous and subcutaneous masses of the extremities in the first four decades. Only 9 cases of congenital tumors are reported. A case of congenital plexiform cellular schwannoma, presenting as a cutaneous mass measuring 3.5 × 2.5 × 2.0 cm, excised from the left upper arm of a 16 month old female is discussed. Regions of increased cellularity and proliferation co-localized and were unassociated with nuclear anaplasia. Mitotic figures numbered 7 per 10 400x fields. The tumor cells were strongly immunoreactive for S-100 protein. The MIB-1index was multifocally 25% and p53 protein over expression was present in 50% of nuclei. Following excision with free margins the tumor locally recurred after 16 months. The recurrence was morphologically identical to the original lesion. Recognition of the clinical and morphological characteristics of this rarely encountered benign neoplasm will facilitate in diagnosing this entity. [source]


    Spinal Cord Pilomyxoid Astrocytoma: An Unusual Tumor

    JOURNAL OF NEUROIMAGING, Issue 4 2007
    Mishal Mendiratta-Lala MD
    ABSTRACT We present the imaging findings of a case of spinal pilomyxoid astrocytoma in a 29-year-old woman with history of neck and back pain and weakness of bilateral upper extremities. A contrast-enhanced magnetic resonance (MR) imaging study revealed an extensive intradural extramedullary lesion occupying most of the thecal sac extending from mid cervical up to the lumbosacral region with extensive contrast enhancement. Spinal pilomyxoid astrocytoma is rare with only three reported cases in pediatric population in the literature. This report illustrates the MR findings of an unusual case of intradural extramedullary spinal pilomyxoid tumor in an adult patient. [source]


    Parasellar Solitary Fibrous Tumor of Meninges: Magnetic Resonance Imaging Features With Pathologic Correlation

    JOURNAL OF NEUROIMAGING, Issue 3 2004
    Chung-Ping Lo MD
    ABSTRACT Solitary fibrous tumor (SFT) is a benign mensenchymal neoplasm of spindle-cell origin. The authors report the case of a 50-year-old man with SFT arising from the meninges of the left parasellar region with cavernous sinus involvement. The tumor was demonstrated isointense on T1-weighted and heterogeneously hypointense on T2-weighted magnetic resonance imaging (MRI) with strong contrast enhancement. The preoperative MRI diagnosis was meningioma or hemangiopericytoma. Pathological study revealed an SFT that stained positive immuno-histochemically for CD34 and vimentin. [source]


    An Earlier Menopause as Clinical Manifestation of Granulosa-Cell Tumor: A Case Report

    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Issue 1 2000
    Dr. Hisahiko Hiroi
    Abstract We present a case of a granulosa-cell tumor, which can cause menopause at an earlier than normal age. The hormonal profiles were characterized by undetectable FSH levels associated with an estradiol level compatible with the level seen in perimenopausal women and by a significant increase in the inhibin level. [source]


    Electrolytic ablation is as effective as radiofrequency ablation in the treatment of artificial liver metastases in a pig model

    JOURNAL OF SURGICAL ONCOLOGY, Issue 2 2008
    Sebastian Hinz MD
    Abstract Background The best treatment option for liver metastases is complete surgical resection. Unfortunately, at the time of diagnosis, not all patients are candidates for complete resection. Electrolytic therapy (ECT) is a novel non-thermal method of tissue destruction. We evaluated its safety and effectiveness in comparison with radiofrequency ablation (RFA). Methods Tumor mimics were created by injecting a gel into the pig liver. The volume of the lesions was measured by ultrasound before treatment. The tumor mimics were treated with either RFA or electrolytic ablation. 48 h after treatment the liver was fixed in formalin and subjected to histological examination. Results Histological investigation confirmed that all lesions were completely surrounded by necrosis after treatment with either ECT or RFA. Two different types of necrosis were identified. After RFA the cell membranes disappeared but the nuclei were still intact, whereas after ECT these structures were completely disrupted. After ECT the necrosis was often surrounded by infiltrating lymphocytes. This inflammatory reaction was not apparent after RFA. Conclusion ECT produced predictable and reproducible necrosis in pig livers and was as effective as RFA at destroying a defined target lesion. A local inflammatory reaction after ECT may favour the development of a systemic immune response. Our results indicate that ECT is an alternative treatment option for irresectable liver metastases. J. Surg. Oncol. 2008;98:135,138. © 2008 Wiley-Liss, Inc. [source]


    Intracerebral Plasma Cell Tumor in a Cat: A Case Report and Literature Review

    JOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 4 2004
    Marc J. Greenberg
    First page of article [source]


    An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: Application to glioblastoma treated with bevacizumab

    MAGNETIC RESONANCE IN MEDICINE, Issue 5 2010
    Gregory Z. Ferl
    Abstract Here, we describe an automated nonparametric method for evaluating gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA) kinetics, based on dynamic contrast-enhanced,MRI scans of glioblastoma patients taken before and after treatment with bevacizumab; no specific model or equation structure is assumed or used. Tumor and venous blood concentration-time profiles are smoothed, using a robust algorithm that removes artifacts due to patient motion, and then deconvolved, yielding an impulse response function. In addition to smoothing, robustness of the deconvolution operation is assured by excluding data that occur prior to the plasma peak; an exhaustive analysis was performed to demonstrate that exclusion of the prepeak plasma data does not significantly affect results. All analysis steps are executed by a single R script that requires blood and tumor curves as the sole input. Statistical moment analysis of the Impulse response function yields the area under the curve (AUC) and mean residence time (MRT). Comparison of deconvolution results to fitted Tofts model parameters suggests that and AUC of the Impulse response function closely approximate fractional clearance from plasma to tissue (Ktrans) and fractional interstitial volume (ve) . Intervisit variability is shown to be comparable when using the deconvolution method (11% [] and 13%[AUC]) compared to the Tofts model (14%[Ktrans] and 24%[ve]). AUC and both exhibit a statistically significant decrease (P < 0.005) 1 day after administration of bevacizumab. Magn Reson Med 63:1366,1375, 2010. © 2010 Wiley-Liss, Inc. [source]